Medical Devices

DexCom Comments on SVB Relationship

SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ: DXCM), today issued the following statement in response to speculation following the developments at Silicon Valley Bank, including a...

Admin - March 14, 2023

DermaSensor Unveils Study Results Demonstrating Ability to Detect Skin Cancer With Device Granted FDA Breakthrough Designation

Industry News March 17, 2023

Agendia Announces First Patient Enrolled in PROOFS Registry Trial to Determine Optimal Treatment and Ability to Forgo Chemotherapy for Premenopausal Women with Early HR+...

Industry News March 17, 2023

Matrivax Initiates Phase 1 Clinical Development of MVX01, a Novel Pneumococcal Vaccine Candidate

Industry News March 17, 2023

Kuria Therapeutics Completes FDA Pre-IND Consultation for Topical Nrf2 Activator for Corneal Endothelial Disease

Industry News March 17, 2023

FDA Advisory Committee Votes in Support of Favorable Benefit-Risk Profile for Pfizer’s PAXLOVID™

Regulatory Affairs March 17, 2023

Merck Provides Update from Open-Label Arm of Phase 2 KeyVibe-002 Trial Evaluating MK-7684A, a Coformulation of Vibostolimab and Pembrolizumab, in Previously Treated Patients with...

Industry News March 17, 2023

Alpine Immune Sciences to Present Povetacicept (ALPN-303) Phase 1 (RUBY-1) Study Data at the 2023 American Academy of Dermatology Annual Meeting

Industry News March 17, 2023

AutoCruitment Adds to Executive Team; Opens New Raleigh, North Carolina, Office

Look Who’s On the Move! March 14, 2023

Direct Biologics Reports Compelling Results From Phase 2 Trial With ExoFlo™ in Hospitalized Patients With Respiratory Failure or Moderate-to-Severe Acute Respiratory Distress Syndrome (ARDS)...

Industry News March 14, 2023

Catamaran Bio selects OmniaBio as partner to develop and manufacture allogeneic CAR-NK cell therapies

Industry News March 14, 2023

Global Clinical Trial Activity Remained Resilient in 2022 Despite The Continued Pandemic, Says IQVIA Institute

Industry News March 14, 2023

Edgewise Therapeutics to Present on EDG-5506 for Becker and Duchenne Muscular Dystrophy (BMD, DMD) at the 2023 Annual MDA Clinical and Scientific Conference

Industry News March 14, 2023

Eureka Therapeutics Licenses Promising Antibody Targeting Mesothelin from the National Cancer Institute

Industry News March 14, 2023

CN Bio Appoints Deepak Singh as Vice President of Sales and Marketing

Look Who’s On the Move! March 14, 2023

Out of Control: U.S. Employers Spend $245B a Year on Diabetes as Diagnosis Rates Rise, New Nomi Health Data Shows

Industry News March 14, 2023

Medical Devices

Recent Articles